China Universal Asset Management Co., Ltd. Agios Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 12,092 shares of AGIO stock, worth $332,771. This represents 0.04% of its overall portfolio holdings.
Number of Shares
12,092
Previous 10,942
10.51%
Holding current value
$332,771
Previous $486,000
18.31%
% of portfolio
0.04%
Previous 0.05%
Shares
15 transactions
Others Institutions Holding AGIO
# of Institutions
243Shares Held
59.9MCall Options Held
270KPut Options Held
332K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$156 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$155 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$134 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$96.7 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$66.7 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.51B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...